Selective aspects of chemotherapy in acute luekemia and Burkitt's tumor
β Scribed by David P. Rall
- Publisher
- John Wiley and Sons
- Year
- 1968
- Tongue
- English
- Weight
- 485 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Of 157 long-term survivors with acute leukemia, 103 are Iiving and well with no evidence of disease (NED) 5 to 17 years from the diagnosis. Of these 103, 48 have been off therapy for a year or more, 43 for 2 or more years, 29 f o r 5 years or more, and 10 f o r 10 years or more. Survival curves sugg
Twenty-eight patients with acute non-lymphoblastic leukemia (ANLL) were started on induction chemotherapy consisting of Cytosine Arbinoside (Ara C) and 6 thioguanine (TG). Daunoruhicin (DNR) was used selectively in 20 of 28 patients who failed to respond by day 14 to the Ara C and TG combination. Se